Answer
Yes, atropine sulfate rapidly crosses the placenta, as shown in late-pregnancy studies, with peak foetal cord blood concentrations about 5 minutes after intravenous doses; safety in human pregnancy is insufficiently established, so use should be limited to when the physician considers it essential.
Sources for this answer
- Atropine Sulfate 600 micrograms/ml solution for injectionhameln pharma ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked